Abstract:Objective: The importance of dimensional approaches is widely recognized, but an empirical base for clinical application is lacking. This is particularly true for irritability, a dimensional phenotype that cuts across many areas of psychopathology and manifests early in life. We examine longitudinal, dimensional patterns of irritability and their clinical import in early childhood. Method: Irritability was assessed longitudinally over an average of 16 months in a clinically enriched, diverse community sample of preschoolers (N = 497; mean = 4.2 years; SD = 0.8). Using the Temper Loss scale of the Multidimensional Assessment Profile of Disruptive Behavior (MAP-DB) as a developmentally sensitive indicator of early childhood irritability, we examined its convergent/divergent, clinical, and incremental predictive validity, and modeled its linear and nonlinear associations with clinical risk. Results: The Temper Loss scale demonstrated convergent and divergent validity to child and maternal factors. In multivariate analyses, Temper Loss predicted mood (separation anxiety disorder [SAD], generalized anxiety disorder [GAD], and depression/dysthymia), disruptive (oppositional defiant disorder [ODD], attention-deficit/hyperactivity disorder [ADHD], and conduct disorder [CD]) symptoms. Preschoolers with even mildly elevated Temper Loss scale scores showed substantially increased risk of symptoms and disorders. For ODD, GAD, SAD, and depression, increases in Temper Loss scale scores at the higher end of the dimension had a greater impact on symptoms relative to increases at the lower end. Temper Loss scale scores also showed incremental validity over DSM-IV disorders in predicting subsequent impairment. Finally, accounting for the substantial heterogeneity in longitudinal patterns of Temper Loss significantly improved prediction of mood and disruptive symptoms. Conclusion: Dimensional, longitudinal characterization of irritability informs clinical prediction. A vital next step will be empirically generating parameters for the incorporation of dimensional information into clinical decision-making with reasonable certainty.

Infectious diseases: annual review of significant publications.

Early Predictors and Concurrent Correlates of Tonic and Phasic Irritability in Adolescence

Parent and Teacher Ratings of Tonic and Phasic Irritability in a Clinical Sample

Is irritability multidimensional: Psychometrics of The Irritability and Dysregulation of Emotion Scale (TIDES-13)

Editorial: Journal of Shipping and Trade

Irritability in Youths: A Critical Integrative Review

Clinical Implications of a Dimensional Approach: The Normal:Abnormal Spectrum of Early Irritability

[Biochemical nature of complement-fixing antigen of arenaviruses].

What I see, what you say: How cross‐method variation sharpens characterization of irritability in early childhood

Concurrent and longitudinal neurostructural correlates of irritability in children

Anger and Positive Reactivity in Infancy: Effects on Maternal Report of Surgency and Attention Focusing in Early Childhood

Prevalence of and risk factors for exertional chest pain in older Mexican Americans.

IRRITABILITY IN CHILD AND ADOLESCENT ANXIETY DISORDERS

Measuring Irritability in Early Childhood: A Psychometric Evaluation of the Affective Reactivity Index in a Clinical Sample of 3- to 8-Year-Old Children

The Associations between Child Irritability, Parental Distress, Parental Irritability and Family Functioning in Children Accessing Mental Health Services

Trajectories of Oppositional Defiant Disorder Irritability Symptoms in Preschool Children

Caudate volume is prospectively associated with irritability in toddlerhood: A preliminary investigation

Phasic Versus Tonic Irritability and Associations with Family Accommodation Among Youth with Selective Mutism: A Latent Profile Analysis

Responses of neonates to parents' and others' voices.

The longitudinal relationship between socioemotional difficulties and irritability in ADHD

Cross-Sectional and Longitudinal Relations Among Irritability, Attention-Deficit/Hyperactivity Disorder Symptoms, and Inhibitory Control